Clinical Trial Update: Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the use of Butylphthalide for cognitive impairment in elderly patients with focal epilepsy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Focal Epilepsy

Drugs mentioned

• Butylphthalide (butylphthalide)

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Focal Epilepsy, Cognitive Impairment | Phase 4 | Status: RECRUITING